Wilmington Savings Fund Society FSB lifted its holdings in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 142.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,986 shares of the company’s stock after purchasing an additional 1,752 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Bath & Body Works were worth $116,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the business. Fifth Third Wealth Advisors LLC lifted its position in shares of Bath & Body Works by 4.9% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock worth $271,000 after purchasing an additional 324 shares in the last quarter. TD Private Client Wealth LLC lifted its position in shares of Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after purchasing an additional 335 shares in the last quarter. Avior Wealth Management LLC lifted its position in shares of Bath & Body Works by 30.3% in the fourth quarter. Avior Wealth Management LLC now owns 1,950 shares of the company’s stock worth $76,000 after purchasing an additional 453 shares in the last quarter. Finally, Golden State Wealth Management LLC bought a new stake in shares of Bath & Body Works in the fourth quarter worth $26,000. Institutional investors own 95.14% of the company’s stock.
Analyst Ratings Changes
Several research firms have issued reports on BBWI. Piper Sandler upped their price target on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. JPMorgan Chase & Co. upped their price target on shares of Bath & Body Works from $39.00 to $41.00 and gave the stock a “neutral” rating in a research report on Friday, January 24th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $42.00 price target on shares of Bath & Body Works in a research report on Monday, November 25th. Finally, Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, Bath & Body Works presently has a consensus rating of “Moderate Buy” and an average target price of $43.19.
Bath & Body Works Stock Performance
BBWI stock opened at $36.46 on Friday. The company’s 50-day simple moving average is $37.63 and its 200 day simple moving average is $33.69. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99. The company has a market capitalization of $7.90 billion, a PE ratio of 8.89, a price-to-earnings-growth ratio of 0.90 and a beta of 1.83.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same period in the prior year, the company posted $0.48 earnings per share. Bath & Body Works’s revenue was up 3.1% compared to the same quarter last year. On average, analysts forecast that Bath & Body Works, Inc. will post 3.26 EPS for the current year.
Bath & Body Works Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.19%. Bath & Body Works’s payout ratio is 19.51%.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles
- Five stocks we like better than Bath & Body Works
- What is a SEC Filing?
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- The How and Why of Investing in Gold Stocks
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.